At a glance
ClinicalIndex Comparison RecordN/ACompleted· 35 enrolled
Drug / intervention
Blood samplingother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of Hypoalbuminemia on Voriconazole Pharmacokinetics in Critically Ill Adult Patients.
In Brief
An observational study evaluating Blood sampling for Focus of the Study:Protein Binding Characteristics of Voriconazole.. Completed, enrolled 35 participants across 1 site.
Detailed Summary
The purpose of this study is to investigate the influence of hypoalbuminemia on the protein binding characteristics of the antifungal drug voriconazole in ICU patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesBelgium
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2013
First PostedMar 2013
Primary CompletionJun 2013
Study CompletionDec 2013
TodayJul 2026
First PostedMar 18, 2013
Enrollment StartFeb 1, 2013
Primary CompletionJun 1, 2013
Study CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 13.3 years ago
Interventions
Blood samplingother
During the treatment of voriconazole, at steady plasma concentrations of voriconazole, one plasma sample and one serum sample are taken.